Navigation Links
New VSL#3® JUNIOR probiotic for children now available

GAITHERSBURG, MD, August 7, 2012 Sigma-Tau Pharmaceuticals, Inc., is excited to introduce a new probiotic medical food for children with IBS. A study published in the Journal of Pediatric Gastroenterology and Nutrition (1) , found that VSL#3, a high-potency probiotic medical food, provided a beneficial role in the dietary management of children who suffer from irritable bowel syndrome (IBS), a common problem for which there is no cure. This finding led Sigma-Tau, distributor of VSL#3, to develop and introduce new VSL#3 JUNIOR; a high-potency probiotic medical food for the dietary management of irritable bowel syndrome (IBS) and ulcerative colitis (UC) in children. New VSL#3 JUNIOR is now available through participating pharmacies behind the counter.

"One of the most obscure consequences of IBS in children is the way these conditions affect their entire family," expresses Mary Ocnean, senior product manager at Sigma-Tau Pharmaceuticals. "VSL#3 has been clinically proven to provide significant improvement in family life disruption scores and in reducing the discomfort and bloating of IBS. It is the first probiotic medical food that has been studied in a pediatric, randomized, double-blind, placebo-controlled crossover trial for children. It was a natural next step for us to extend the line of VSL#3 products with a pediatric version and we're happy to announce that it is now available to consumers in a once daily formulation," adds Ocnean.

Unlike other probiotics, VSL#3 JUNIOR is a medical food and requires refrigeration to preserve its 8 proprietary strains of 225 billion live bacteria, making it one of the few probiotics with this many strains and about 50 times more potent than the average probiotic (2) . VSL#3 JUNIOR is all-natural and comes in watermelon, a kid-pleasing flavor, making compliance less of an issue.

"There has been extensive clinical research in patients who added VSL#3 to their daily regimen, and the evidence shows that this probiotic plays a beneficial role in the dietary management of children suffering with IBS and UC (3) . IBS patients receiving VSL#3 also had significantly greater improvements versus both baseline and placebo in discomfort, bloating, gassiness and family assessment of life disruption (1). For young patients with UC, VSL#3 JUNIOR offers a tasty alternative to current VSL#3 products," says Ocnean. VSL#3 JUNIOR can be mixed into cold drinks, such as water and juice or foods like applesauce or ice cream, making it easy for children who find taking medication difficult. Adjustment of the intestinal flora can take a few days or weeks; it may take up to one month for the colonization of the gut to become optimally stable. All natural VSL#3 JUNIOR is gluten free, is Kosher and Halal certified, and a non-dairy product. Each box contains 30 watermelon flavored packets. As with all forms of VSL#3, they must be used under medical supervision.

Contact: Nicole Egan
Robin Leedy & Associates, Inc.

Related medicine news :

1. Probiotic Products May Prevent Antibiotic-Linked Diarrhea
2. Food hypersensitivity and otolaryngologic conditions in young children
3. Mothers, children underestimate obesity in China
4. Preschool children who can pay attention more likely to finish college
5. Adalimumab is a promising therapy for children with Crohns disease
6. Medical complications in hospitalized children: The Canadian Paediatric Adverse Events Study
7. Women and Children First? Not So, Says Study
8. Neglect May Harm Brain Growth in Children
9. Wayne State develops better understanding of memory retrieval between children and adults
10. Heavy Drinking in Pregnancy Linked to Host of Problems in Children
11. New lipid screening guidelines for children overly aggressive, UCSF researchers say
Post Your Comments:
(Date:11/24/2015)... N.J. (PRWEB) , ... November 25, 2015 , ... ... delivery technologies and development solutions for drugs, biologics, consumer health and global clinical ... will present at the upcoming Clinical Trial Supply East Asia Conference, to be ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Preparing for ... p.m. – 3:00 p.m. EST, , FDA has long asserted that ... regulations apply to performing the tests and do not meet the device regulations. , ...
(Date:11/24/2015)... ... November 24, 2015 , ... Brillouin Energy Corp. Congress ... the developer of renewable energy technologies capable of producing commercially useful amounts of ... that its WET™ and HHT™ Boiler System reactor core modules were presented to ...
(Date:11/24/2015)... PLAINSBORO, N.J. (PRWEB) , ... November 24, 2015 ... ... experts will gather to share their knowledge and experiences at a live taping ... during the Ruesch Center for the Cure of Gastrointestinal Cancers 2015 Symposium at ...
(Date:11/24/2015)... Marne, MI (PRWEB) , ... November 24, 2015 , ... ... has released a series of recent video interviews with some of the staff members ... life at the residential treatment facility, as well as some of the things that ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... -- Avery Biomedical Devices (ABD), manufacturer of the Avery ... of Anders Jonzon , MD; Ph.D. as clinical ... Dr. Jonzon is a Physiologist and consultant in ... Uppsala and Children,s Hospital, Karolinska, Stockholm, Sweden ... the Cardiovascular Institute (UCSF). His research has covered circulation, ...
(Date:11/24/2015)... , November 24, 2015 ... of the University of Bern ... Nutrition of the Bern University Hospital "Inselspital" are proud ... develop a novel generation artificial pancreas. Combining a fully ... for diabetic patients with the unequalled accuracy of an ...
(Date:11/24/2015)... 2015 Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today ... Services, Education and Human Resources will be presenting in the ... Health Plan Strategies for a Dynamic Market" on Dec. 1, ... a consultant with the Cambridge Advisory Group, where she leads ... The webinar will discuss the rapid growth of oral ...
Breaking Medicine Technology: